Patent · US Active

Lipase inhibiting composition

US8039508B2 · kind B2 · utility

1Cited by

8References

62Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Karsten Maeder · Glückstadt, DE
Rainer E. Martin · Basel, CH
Susanne Raab · Echterdingen, DE
Lukas Scheibler · Laguna Beach, US
Thomas Schindler · Soest, DE
Marco Schroeder · Heidelberg, DE

Key dates

Filing date	Dec 23, 2004
Grant date	Oct 18, 2011
Priority date	—
Expiry date	Jul 7, 2026

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Pharmaceutical compositions that contain a lipase inhibitor having a melting point ≧37° C., a sucrose fatty acid ester wherein the sucrose fatty acid ester is a mono-, di-, tri- or tetra-ester, and optionally one or more pharmaceutically acceptable excipients, are useful for treatment of obesity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.